Back
Travere Therapeutics Vs. Apogee Enterprises Industry Stock Comparison
Buy
56
TVTX
Travere Therapeutics
Last Price:
8.2200
Seasonality Move:
1.04%
Buy
61
APOG
Apogee Enterprises
Last Price:
63.05
Seasonality Move:
0.92%
Buy
56
Travere Therapeutics (TVTX)
is a Buy
Is Travere Therapeutics a Buy, Sell or Hold?
- The current Travere Therapeutics [TVTX] share price is $8.2200. The Score for TVTX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- TVTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Apogee Enterprises (APOG)
is a Buy
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $63.06. The Score for APOG is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- APOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TVTX Stock Price Chart
What is Travere Therapeutics's stock price today?
-
The Travere Therapeutics share price today is $8.2200
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $63.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APOG is experiencing slight selling pressure.
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 65.88 | Buy |
| Chaikin Money Flow: | 1345545 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.806 - 7.866) | Buy |
| Bollinger Bands (100): | (6.3273 - 8.1073) | Buy |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 52.89 | Buy |
| Chaikin Money Flow: | -136947 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.7 - 64.72) | Buy |
| Bollinger Bands (100): | (56.24 - 63.86) | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.73 | Buy |
| 20-day SMA: | 7.51 | Buy |
| 50-day SMA: | 6.74 | Buy |
| 200-day SMA: | 7.68 | Buy |
| 8-day EMA: | 7.88 | Buy |
| 20-day EMA: | 7.5 | Buy |
| 50-day EMA: | 7.17 | Buy |
| 200-day EMA: | 8.87 | Sell |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.18 | Buy |
| 20-day SMA: | 61.94 | Buy |
| 50-day SMA: | 63.23 | Sell |
| 200-day SMA: | 54.21 | Buy |
| 8-day EMA: | 61.73 | Buy |
| 20-day EMA: | 62.13 | Buy |
| 50-day EMA: | 62.04 | Buy |
| 200-day EMA: | 56.06 | Buy |
Travere Therapeutics Earnings Growth & TVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.61 per share, an increase next quarter of $0.15 per share, a decrease this year of $2.58 per share, and an increase next year of $2.34 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.67 per share, and an increase next year of $0.11 per share.
Travere Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||